Jeroen Poeze,Marcelo Lamego,Sean Merritt,Cristiano Dalvi,Hung Vo,Johannes Bruinsma,Ferdyan Lesmana,Massi Joe E. Kiani,Greg Olsen
申请号:
US16409304
公开号:
US20190261895A1
申请日:
2019.05.10
申请国别(地区):
US
年份:
2019
代理人:
摘要:
prepared that ranged from 0-55 mg/dL. Five samples were used as a training set and 20 samples were then used as a test population. As shown, embodiments of sensor 101 were able to obtain at least a standard deviation of 37 mg/dL in the training set and 32 mg/dL in the test population.The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.